| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |